Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04717063 · ClinicalTrials.gov registry record · Phase 2
Clinical Efficacy of Single-Use of Peroxyl Mouthwash for Reducing Bacteria Saliva and Bioaerosol Contamination Phase 2
A Phase 2 study, sponsored by Colgate Palmolive.
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
NCT04717063 is a Phase 2 study that has completed, run by Colgate Palmolive. The registered enrollment target is 100 participants.
The verdict
NCT04717063, a Phase 2 study, has completed, sponsored by Colgate Palmolive.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
Study Summary
To evaluate the antibacterial efficacy of a commercial mouthwash containing 1.5% hydrogen peroxide in reducing the levels of bacteria in bioaerosols generated by dental prophylaxis.
Interventions
- DRUG Placebo
- DRUG Peroxyl Oral Product
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-11-16 |
| Est. Completion | 2021-01-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04717063
The ClinicalTrials.gov registry entry for NCT04717063 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Colgate Palmolive, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04717063 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04717063 about?
NCT04717063 is a clinical study titled "Clinical Efficacy of Single-Use of Peroxyl Mouthwash for Reducing Bacteria Saliva and Bioaerosol Contamination Phase 2". To evaluate the antibacterial efficacy of a commercial mouthwash containing 1.5% hydrogen peroxide in reducing the levels of bacteria in bioaerosols generated by dental prophylaxis.
What is the current status of trial NCT04717063?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2020-11-16. Estimated completion is 2021-01-07.
What interventions are being tested in trial NCT04717063?
The interventions under investigation include: Placebo (DRUG), Peroxyl Oral Product (DRUG).
Who is sponsoring clinical trial NCT04717063?
This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.